Peter Young
Follow
Get notifications in MyBN when activity occurs.
Peter Young
Peter Young led the global introduction of combination HIV therapy that revolutionized HIV treatment and quintupled sales. Before joining Bone Medical in 2011, he was chief executive of two private start-up enterprises: AlphaVax, a viral vector vaccine company based in North Carolina and Ikano Therapeutics, a specialty pharma company in New Jersey.
Lists and Charts
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Managing Director | | 2011 - 2014 | 166 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Bone Medical | 31 Jan 2014 | Bought | 23,466,523 | $0.01 | $234,665 | OtherIssue of shares under debt conversion agreement |
| Bone Medical | 03 Jul 2012 | Bought | 163,855 | $0.01 | $2,176 | OtherShares issued in lieu of cash for services rendered |
Powered by Morningstar ®
Equity Capital Markets Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 27/03/14 | Bone Medical | Placement | $3.8m | >> |
Mergers & Acquisitions Deals
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| 12/05/15 | Bone Medical | Takor Group | Reverse takeover | $3.9m | >> |
